Document Type
Article
Publication Date
2-3-2023
Abstract
This report describes the methods and preliminary results for the manuscript titled, “Spending on Phased Clinical Development of Approved Drugs by the US National Institutes of Health Compared With Industry.”
DOI
https://doi.org/10.5281/zenodo.7603331
Recommended Citation
Zhou, Edward; Jackson, Matthew; and Ledley, Fred, 2023. Tech Note 2023-1 NIH Contribution to Phased Clinical Development of Drugs Approved from 2010-2019, CISI Publication.
Included in
Pharmaceutics and Drug Design Commons, Pharmacy Administration, Policy and Regulation Commons